EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heat-killed postbiotic EF-2001® improves gastrointestinal health in overweight adults: A randomized, double-blind, placebo-controlled trial

Ranjith Kumar Manoharan, Hyun-Dong Shin, Yura Lee, Sunhwa Baek, Eunjung Moon, Youn Bum Park, Junhui Cho, Sanjay Vaze, Kwon-Il Han, Sathiyaraj Srinivasan

Journal of Functional Foods · 2026-11 · 146 · 107536

DOI: 10.1016/j.jff.2026.107536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Functional Foods, 2026-11. Verfasst von Ranjith Kumar Manoharan und 9 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A diverse, functionally resilient gut microbiome supports metabolic, immune, and gastrointestinal (GI) health. This trial evaluated heat-killed Enterococcus faecalis EF-2001 (EF-2001®) on GI symptoms, quality of life, and gut microbiome composition in adults with excess weight and mild-to-moderate GI discomfort. In this 84-day randomized, double-blind, placebo-controlled, parallel-group trial, 209 adults aged 18–45 years were randomized (1:1:1) to receive EF-2001® (≥30 billion cells/day), beLP1® (reported separately), or placebo once daily after breakfast. Per-protocol analyses included 49 participants in the EF-2001® group and 54 in the placebo group. The primary endpoint was change in gastrointestinal symptoms assessed by the Gastrointestinal Symptom Rating Scale (GSRS). Secondary endpoints included perceived stress (PSS), digestion-associated quality of life (DQLQ), serum TNF-α, lipid parameters, body composition (DEXA), and gut microbiome composition assessed by metagenomic next-generation sequencing. By Day 84, EF-2001® significantly reduced total GSRS scores compared with placebo (mean decrease 9.92 [SD 7.16] units; p = 0.0167). Significant improvements were also observed in perceived stress (PSS decrease 3.45 [SD 6.40] units; p = 0.0163) and digestion-associated quality of life (DQLQ decrease 1.25 [SD 1.90] units; p = 0.0114). Shotgun metagenomic analysis identified exploratory shifts in the gut microbiome, with directional increases in Lactobacillus , Megamonas , and Bifidobacterium and reductions in Escherichia and Klebsiella . However, no taxa reached significance after FDR correction. Serum TNF-α showed a small reduction, while lipid parameters changed minimally. EF-2001® supplementation for 84 days improved GI symptoms, perceived stress and digestion-associated quality of life, while exploratory microbiome analyses identified directional changes in selected taxa.

Zitieren

APA

Manoharan, R. K., Shin, H., Lee, Y., Baek, S., Moon, E., Park, Y. B., Cho, J., Vaze, S., Han, K., & Srinivasan, S. (2026). Heat-killed postbiotic EF-2001® improves gastrointestinal health in overweight adults: A randomized, double-blind, placebo-controlled trial. Journal of Functional Foods, 146, 107536. https://doi.org/10.1016/j.jff.2026.107536

Vancouver

Manoharan RK, Shin H, Lee Y, Baek S, Moon E, Park YB, et al. Heat-killed postbiotic EF-2001® improves gastrointestinal health in overweight adults: A randomized, double-blind, placebo-controlled trial. Journal of Functional Foods. 2026;146:107536. doi:10.1016/j.jff.2026.107536

BibTeX
@article{Manoharan2026,
  author = {Manoharan, Ranjith Kumar and Shin, Hyun-Dong and Lee, Yura and Baek, Sunhwa and Moon, Eunjung and Park, Youn Bum and Cho, Junhui and Vaze, Sanjay and Han, Kwon-Il and Srinivasan, Sathiyaraj},
  title = {Heat-killed postbiotic EF-2001® improves gastrointestinal health in overweight adults: A randomized, double-blind, placebo-controlled trial},
  journal = {Journal of Functional Foods},
  year = {2026},
  volume = {146},
  pages = {107536},
  doi = {10.1016/j.jff.2026.107536}
}
Kostenlos starten →